WO2009117112A3 - Powder dispersion apparatu - Google Patents

Powder dispersion apparatu Download PDF

Info

Publication number
WO2009117112A3
WO2009117112A3 PCT/US2009/001716 US2009001716W WO2009117112A3 WO 2009117112 A3 WO2009117112 A3 WO 2009117112A3 US 2009001716 W US2009001716 W US 2009001716W WO 2009117112 A3 WO2009117112 A3 WO 2009117112A3
Authority
WO
WIPO (PCT)
Prior art keywords
apparatuses
apparatu
devices
powder dispersion
receptacle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/001716
Other languages
French (fr)
Other versions
WO2009117112A2 (en
Inventor
Mark Glusker
William W. Alston
George S. Axford
John Palmer-Felgate
Jonathan Wilkins
Willard R. Foss
Nagaraja Rao
Mark Postich
Neeraj R. Pakala
David S. Maltz
Jeffry G. Weers
Gal Cohen
Keith Try Ung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to EP09722897A priority Critical patent/EP2257326A2/en
Publication of WO2009117112A2 publication Critical patent/WO2009117112A2/en
Publication of WO2009117112A3 publication Critical patent/WO2009117112A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0038—Cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Methods and apparatuses for the pulmonary delivery of a composition, such as methods and apparatuses for dispersing dry powder medicaments for inhalation by a patient. Elements or aspects of the apparatuses, including receptacle puncturing mechanisms (H), deoccluding devices (G), receptacle impacting devices (N), and receptacle lock devices (M) or systems.
PCT/US2009/001716 2008-03-21 2009-03-18 Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents Ceased WO2009117112A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09722897A EP2257326A2 (en) 2008-03-21 2009-03-18 Powder dispersion apparatus

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7026008P 2008-03-21 2008-03-21
US61/070,260 2008-03-21
US12607808P 2008-04-30 2008-04-30
US61/126,078 2008-04-30

Publications (2)

Publication Number Publication Date
WO2009117112A2 WO2009117112A2 (en) 2009-09-24
WO2009117112A3 true WO2009117112A3 (en) 2010-04-22

Family

ID=40792785

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001716 Ceased WO2009117112A2 (en) 2008-03-21 2009-03-18 Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents

Country Status (2)

Country Link
EP (1) EP2257326A2 (en)
WO (1) WO2009117112A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5570996B2 (en) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド Delivery of aerosolizable foodstuffs
US8399006B2 (en) 2009-01-29 2013-03-19 Forsight Vision4, Inc. Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
PT105065B (en) 2010-04-26 2012-07-31 Hovione Farmaciencia S A A SIMPLE INHALER OF CAPSULES
SI2600812T1 (en) 2010-08-05 2021-12-31 ForSight Vision4, Inc., Apparatus to treat an eye
JP6111194B2 (en) 2010-08-05 2017-04-05 フォーサイト・ビジョン フォー・インコーポレーテッド Combination drug delivery method and apparatus
EP3861969A1 (en) 2010-08-05 2021-08-11 ForSight Vision4, Inc. Injector apparatus for drug delivery
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
WO2012068549A2 (en) 2010-11-19 2012-05-24 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
JOP20120023B1 (en) 2011-02-04 2022-03-14 Novartis Ag Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
EP4249059B1 (en) 2011-06-28 2025-07-30 ForSight Vision4, Inc. An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
RS61758B1 (en) 2011-09-16 2021-05-31 Forsight Vision4 Inc Fluid exchange apparatus
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
HK1212348A1 (en) 2012-12-19 2016-06-10 Novartis Ag Autotaxin inhibitors
CA2905496A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
ES2972168T3 (en) 2013-03-28 2024-06-11 Forsight Vision4 Inc Ophthalmic implant for administration of therapeutic substances
US20160168119A1 (en) 2013-07-18 2016-06-16 Novartis Ag Autotaxin inhibitors
MX368059B (en) 2013-07-18 2019-09-18 Novartis Ag Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core.
US20170037030A1 (en) 2014-04-24 2017-02-09 Novartis Ag Autotaxin inhibitors
EP3169289B1 (en) 2014-07-15 2020-04-15 ForSight Vision4, Inc. Ocular implant delivery device
BR112017002466A2 (en) 2014-08-08 2017-12-05 Forsight Vision4 Inc stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods for their preparation
WO2016077371A1 (en) 2014-11-10 2016-05-19 Forsight Vision4, Inc. Expandable drug delivery devices and method of use
RU2715687C2 (en) * 2015-04-15 2020-03-02 Филип Моррис Продактс С.А. Powder inhaler and method for use thereof
CA3005238A1 (en) 2015-11-20 2017-05-26 Forsight Vision4, Inc. Porous structures for extended release drug delivery devices
JP7009384B2 (en) 2016-04-05 2022-01-25 フォーサイト・ビジョン フォー・インコーポレーテッド Implantable eye drug delivery device
US10898494B2 (en) * 2016-05-05 2021-01-26 Liquidia Technologies, Inc. Dry powder treprostinil for the treatment of pulmonary hypertension
KR20200093581A (en) 2017-11-21 2020-08-05 포사이트 비젼4, 인크. Fluid exchange devices and methods of use for scalable port delivery systems
CN111834656B (en) * 2020-07-25 2022-03-22 山东交通学院 An optimized single-phase doped lanthanum gallate electrolyte preparation device and method
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
WO2025096521A1 (en) * 2023-10-30 2025-05-08 Insmed Incorporated Medicament delivery device, cover, and methods of medicament delivery

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888253A (en) * 1972-08-04 1975-06-10 Beecham Group Ltd Device for administration of medicines
WO1999039760A1 (en) * 1998-02-05 1999-08-12 Unisia Jecs Corporation Inhalant medicator
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
WO2006054021A2 (en) * 2004-11-16 2006-05-26 Valois Sas Fluid product dispensing device
WO2008051621A2 (en) * 2006-10-25 2008-05-02 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888253A (en) * 1972-08-04 1975-06-10 Beecham Group Ltd Device for administration of medicines
WO1999039760A1 (en) * 1998-02-05 1999-08-12 Unisia Jecs Corporation Inhalant medicator
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
WO2006054021A2 (en) * 2004-11-16 2006-05-26 Valois Sas Fluid product dispensing device
WO2008051621A2 (en) * 2006-10-25 2008-05-02 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices

Also Published As

Publication number Publication date
WO2009117112A2 (en) 2009-09-24
EP2257326A2 (en) 2010-12-08

Similar Documents

Publication Publication Date Title
WO2009117112A3 (en) Powder dispersion apparatu
WO2008051621A3 (en) Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
WO2009008001A3 (en) Inhalation device
IL226853A (en) 3-[(1,2-oxazol-4-yl)methoxy]-8-azabicyclo[3.2.1]octane derivatives, processes for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments for the treatment of fxr-mediated conditions
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
WO2012016889A3 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
WO2011041461A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2012078593A3 (en) Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
IL198289A (en) Substituted dihydropyrazolones, processes for their preparation, medicaments comprising them and their use for the preparation of such medicaments
IL233677A (en) Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments
IL248246B (en) (2s,5r)-6-(benzyloxy/allyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylates, process for their preparation and use of (2s,5r)-tert-butyl-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboyxlate for preparing anti-infective medicaments
PH12012500631A1 (en) Improvements to pressurised metered dose inhalers
WO2011041694A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2011017350A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2010037059A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
HK1221653A1 (en) Compositions, methods & systems for respiratory delivery of three or more active agents
WO2014031610A8 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
WO2007117661A3 (en) Drug microparticles
WO2012075407A3 (en) Blood collection devices containing blood stabilization agent
UA103668C2 (en) Dry powder inhaler device and lock mechanism
EP4316473A3 (en) Use of stearate in an inhalable formulation
WO2010021607A3 (en) Pharmaceutical formulation
WO2011084316A3 (en) Formulations and methods for controlling mdi particle size delivery
WO2011008662A9 (en) Powder delivery devices and methods of using the same
MX2010005036A (en) Dry powder formulations comprising ascorbic acid derivates.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09722897

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009722897

Country of ref document: EP